Andere talen Venus Remedies Limited NSE India S.E.

Aandelen

VENUSREM

INE411B01019

Vertraagde tijd NSE India S.E. Andere beurzen 11:39:48 02-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
372 ^INR	+3,46%		-0,47%	-8,43%

13/06	Venus Remedies krijgt aanbesteding van UNICEF voor antibioticum Ceftriaxone	MT
30/05	Venus Remedies Limited rapporteert resultaten voor het vierde kwartaal en het volledige jaar eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Venus Remedies Bags Tender from UNICEF for Antibiotic Ceftriaxone	13/06
Venus Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	30/05
Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs	19/03
Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products	08/03
Venus Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Venus Remedies Gets Ukraine Marketing Approval for Chemotherapy Drug, Antibiotics	13/02
Venus Remedies Gets Marketing Authorization in Malta for Two Chemotherapy Drugs	12/01
Venus Remedies Gets Authorization to Market Cancer Drugs in Israel, Colombia	21/12
Indian Equities Clock Sharp Losses on Wednesday Due to Widespread Selling	20/12
Venus Remedies Expands Into Wellness Business	20/12
Venus Remedies Gets Bahrain Marketing Authorization for Enoxaparin	19/12
Indian Equities Score Another Record Highs on Tuesday, Lifted by Ruling Party's State Polls Win	05/12
Venus Remedies Gets Azerbaijan's Marketing Approval for Blood Clot Prevention Drug	05/12
Venus Remedies Gets Marketing Approval for Cancer Drugs in Philippines, Saudi Arabia	01/12
Venus Remedies Limited Receives Market Authorizations in Saudi Arabia and Philippines	01/12
Venus Remedies' Consolidated Profit Jumps in Fiscal Q2	27/11
Venus Remedies Arm Gets Authorization to Market Cancer Drug in UK	26-10-23
Venus Remedies Secures Marketing Approval for Six Key Chemotherapy Drugs in Philippines	16-10-23
Venus Remedies Limited Receives Marketing Approval from the Philippines for Six Key Chemotherapy Drugs	16-10-23
Venus Remedies Launches Antibiotic Elores in Ecuador	12-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Venus Remedies Limited NSE India S.E.

Aandelen

VENUSREM

INE411B01019

Andere talen

Filters